Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 32Colorectal Neoplasms 10Prostatic Neoplasms 9Ovarian Neoplasms 5Lung Neoplasms 5Triple Negative Breast Neoplasms 3Endometrial Neoplasms 3Anatomic Stage I Breast Cancer AJCC v8 3Pain 2Neoplasms, Plasma Cell 2Neoplasms 2Gastrointestinal Neoplasms 2Breast Carcinoma In Situ 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Stomach Neoplasms 1Patient Compliance 1Pancreatic Neoplasms 1Neoplastic Syndromes, Hereditary 1Neoplasms, Second Primary 1Multiple Myeloma 1Motor Activity 1Lymphoma 1Invasive Breast Carcinoma 1Inflammatory Breast Neoplasms 1Hematologic Neoplasms 1Head and Neck Neoplasms 1

Interventions

Surveys and Questionnaires 1Standard of Care 1Interviews as Topic 1High-Throughput Nucleotide Sequencing 1Genetic Testing 1Genetic Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplastic Syndromes, Hereditary × Interviews as Topic × Breast × Clear all
NCT04763915 2025-09-19

IMPACT

Vanderbilt-Ingram Cancer Center

Phase NA Active not recruiting
720 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡